Symposia: Aggressive Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Hodgkin lymphoma, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Epidemiology, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, B Cell lymphoma, Clinical Research, Health outcomes research, T Cell lymphoma, Pediatric, Diseases, Indolent lymphoma, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Metabolism, Registries, Young adult , Biological Processes, Emerging technologies, Survivorship, Technology and Procedures, Study Population, Human, Imaging, Machine learning, Transplantation (Allogeneic and Autologous)
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Hodgkin lymphoma, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Epidemiology, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, B Cell lymphoma, Clinical Research, Health outcomes research, T Cell lymphoma, Pediatric, Diseases, Indolent lymphoma, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Metabolism, Registries, Young adult , Biological Processes, Emerging technologies, Survivorship, Technology and Procedures, Study Population, Human, Imaging, Machine learning, Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH